Mobilizing antitumour immunity through vaccination potentially constitutes a powerful
anticancer strategy but has not yet provided robust clinical benefits in large patient …

Dendritic cells (DCs) occupy a central position in the immune system, orchestrating a wide
repertoire of responses that span from the development of self-tolerance to the elicitation of …

Objectives Tolerogenic dendritic cells (tolDCs) constitute a promising experimental
treatment for targeting autoreactive T cells in autoimmune diseases, including rheumatoid …

Dendritic cells (DCs) are professional antigen-presenting cells, orchestrating innate and
adaptive immunity during infections, autoimmune diseases, and malignancies. Since the …

Many clinical trials have been carried out or are in progress to assess the therapeutic
potential of dendritic-cell-(DC-) based vaccines on cancer patients, and recently the first DC …

Extracorporeal Photochemotherapy (ECP) is a widely used therapy for cutaneous T cell
lymphoma (CTCL). Although the mechanism of clinical action of ECP is not precisely …

The clinical application of dendritic cells (DC) as adjuvants in immunotherapies such as the
cell-based cancer vaccine continues to gain interest. The overall efficacy of this emerging …

Dendritic cells (DCs) are professional antigen-presenting cells, necessary for the initiation
and maintenance of antigen-specific immunity and tolerance. Decades of research have …

Introduction 3. DC Immunobiology 4. Dendritic Cell Subpopulations 5. The type1/type 2
dualism and cancer 6. Generation of DC for Therapy 7. Consideration of DC Maturation …

Cancer cells evolve from normal cells throughout life and are usually recognized by our
immune system and destroyed, a process called immunosurveillance. Unfortunately, in …